SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 74 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,864,000 | -89.0% | 1,169 | -67.9% | 0.00% | – |
| Q3 2014 | $26,011,000 | +410.1% | 3,643 | +365.9% | 0.00% | – |
| Q2 2014 | $5,099,000 | +42.4% | 782 | +12.0% | 0.00% | – |
| Q1 2014 | $3,581,000 | -26.5% | 698 | -32.1% | 0.00% | – |
| Q4 2013 | $4,873,000 | -92.4% | 1,028 | -91.6% | 0.00% | – |
| Q2 2013 | $63,708,000 | – | 12,228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
| GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
| BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
| DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
| Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
| DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
| Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |